Urgent.News

What's breaking now, across hundreds of outlets.

Business

A Nobel Prize Winner’s Startup Raised $350 Million. Now It Can’t Fund Its Cancer Programs

The Berkeley gene-editing company will wind down its lymphoma and myeloma studies and explore a potential sale.

A Nobel Prize Winner’s Startup Raised $350 Million. Now It Can’t Fund Its Cancer Programs

We haven't written up this one. Inc. has the full story — the link below goes straight to it.

Source: inc.com

Read the original at inc.com →

Report a problem with this story

More in Business

ELD Data Needs An Enforceable Standard

Editor’s note: This is a contributed commentary. It comes amid FMCSA’s ongoing revocation of registered ELDs over hours-of-service log manipulation and FreightWaves welcomes responses from other parties. An ELD connection has become an important part of how freight moves.

The EU–MERCOSUR Deal Changes the Game for Ukrainian Agri-Food Exports

The EU–MERCOSUR trade agreement is creating new competitive pressure for Ukrainian agricultural exporters just as Kyiv is seeking deeper integration with the European market. The agreement, signed in January and provisionally applied since May 1, 2026, gives Argentina, Brazil, Paraguay and Uruguay preferential access to the EU market.

More from Wednesday 7 October →